SAFETY OF TRALOKINUMAB IN PAEDIATRIC PATIENTS AGED 12-17 WITH MODERATE-TO-SEVERE AROPIC DERMATITIS: RESULTS FROM THE PHASE 3 ECZTRA 6 TRIAL

被引：0

作者：

Wollenberg, Andreas ^{[1
,2
]}

Cork, Michael J. ^{[3
,4
]}

Flohr, Carsten ^{[5
,6
]}

Bewley, Anthony ^{[7
]}

Blauvelt, Andrew ^{[8
]}

Hong-H, Chih-Ho ^{[9
]}

Imafuku, Shinichi ^{[10
]}

Schuttelaar, Marie-Louise Anna ^{[11
]}

Simpson, Eric ^{[12
]}

Soong, Weily ^{[13
]}

Amoudruz, Petra ^{[14
]}

Lophaven, Katja ^{[14
]}

Kurbasic, Azra ^{[14
]}

Soldbro, Lise ^{[14
]}

Vest, Natacha ^{[14
]}

Paller, Amy ^{[15
]}

机构：

[1] Ludwig Maximilian Univ Munich, Dept Dermatol & Allergy, Munich, Germany

[2] Vrije Univ Brussel VUB, Univ Ziekenhuis Brussel UZ Brussel, Dept Dermatol, Brussels, Belgium

[3] Univ Sheffield, Dept Infect Immun & Cardiovasc Dis, Sheffield Dermatol Res, Sheffield, S Yorkshire, England

[4] Sheffield Teaching Hosp, NIHR Clin Res Facil, Sheffield, S Yorkshire, England

[5] Guys St Thomas NHS Fdn Trust, St Johns Inst Dermatol, Dept Paediattol, St John, NF, Canada

[6] Kings Coll London, London, England

[7] Barts Hlth NHS Trust, London, England

[8] Oregon Med Res Ctr, Portland, OR USA

[9] Univ British Columbia, Vancouver, BC, Canada

[10] Fukuoka Univ, Fukuoka, Japan

[11] Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands

[12] Oregon Hlth & Sci Univ, Portland, OR USA

[13] Allervie Hlth Alabama Allergy & Asthma Ctr, Birmingham, AL USA

[14] LEO Pharma AS, Ballerup, Denmark

[15] Northwestern Univ, Feinberg Sch Med, Chicago, IL USA

来源：

JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT | 2023年 / 21卷

关键词：

D O I：

暂无

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

P067

引用

页码：58 / 58

页数：1

共 50 条

[41] Integrated safety analysis of abrocitinib for the treatment of moderate-to-severe atopic dermatitis (AD) from the phase 2 and phase 3 clinical trial program
Simpson, Eric L.
Silverberg, Jonathan I.
Nosbaum, Audrey
Winthrop, Kevin
Guttman-Yassky, Emma
Hoffmeister, Karin M.
Zhang, Min
Farooqui, Saleem A.
Johnson, Susan
Thorpe, Andrew
Rojo, Ricardo
[J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB150 - AB150
[42] Efficacy and safety of abrocitinib in Chinese patients with moderate-to-severe atopic dermatitis: A post hoc analysis of the JADE REGIMEN phase 3 trial
Li, Hang
Cheng, Hao
Lu, Qianjin
Lai, Wei
Tao, Xiaohua
Encinas, Gerardo A.
Vyas, Shefali
Wang, Bo
Luo, Xin
Li, Shiqi
[J]. CHINESE MEDICAL JOURNAL, 2024, 137 (16) : 1991 - 1992
[43] Efficacy and safety of abrocitinib in Chinese patients with moderate-to-severe atopic dermatitis: A post hoc analysis of the JADE REGIMEN phase 3 trial
Li Hang
Cheng Hao
Lu Qianjin
Lai Wei
Tao Xiaohua
Encinas Gerardo A
Vyas Shefali
Wang Bo
Luo Xin
Li Shiqi
[J]. 中华医学杂志英文版, 2024, 137 (16)
[44] Efficacy and safety of upadacitinib through 140 weeks in adolescents and adults with moderate-to-severe atopic dermatitis: phase 3 randomized clinical trial results
Silverberg, Jonathan, I
Guttman-Yassky, Emma
Simpson, Eric L.
Papp, Kim A.
Blauvelt, Andrew
Chu, Chia-Yu
Hong, H. Chih-ho
Gold, Linda F. Stein
Bieber, Thomas
Kabashima, Kenji
Rosmarin, David
Gamelli, Amy
Calimlim, Brian
Vigna, Namita
Hu, Xiaofei
Yang, Yang
Wu, Xiaoqiang
Huang, Xiaohong
Suravaram, Smitha
Teixeira, Henrique D.
Raymundo, Eliza
Irvine, Alan D.
[J]. BRITISH JOURNAL OF DERMATOLOGY, 2024, 190 : II8 - II8
[45] Laboratory Safety of Dupilumab in Patients Aged 6-11 Years with Severe Atopic Dermatitis: Results from a Phase III Clinical Trial
Paller, Amy S.
Wollenberg, Andreas
Siegfried, Elaine
Thaci, Diamant
Cork, Michael J.
Arkwright, Peter D.
Gooderham, Melinda
Sun, Xian
O'Malley, John T.
Khokhar, Faisal A.
Vakil, Jignesh
Bansal, Ashish
Rosner, Karli
Shumel, Brad
Levit, Noah A.
[J]. PEDIATRIC DRUGS, 2021, 23 (05) : 515 - 527
[46] Improvement in sleep is associated with improved quality of life in adult patients with moderate-to-severe atopic dermatitis: Results from a phase 3 trial of baricitinib therapy
Lio, Peter
Han, George
Lain, Edward
Maari, Catherine
Ball, Susan
Sun, Luna
DeLozier, Amy M.
Buchanan, Andrew
Ding, Yuxin
Eichenfield, Lawrence F.
[J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB14 - AB14
[47] Improvement in sleep and itch and enhanced quality of life in adult patients with moderate-to-severe atopic dermatitis: results from a phase 3 trial of baricitinib therapy
Lio, Peter A.
Simpson, Eric L.
Han, George
Soung, Jennifer
Ball, Susan
Sun, Luna
Casillas, Marta
DeLozier, Amy M.
Ding, Yuxin
Eichenfield, Lawrence F.
[J]. JOURNAL OF DERMATOLOGICAL TREATMENT, 2022, 33 (04) : 2057 - 2062
[48] Laboratory safety from a 16-week phase III study of dupilumab in patients aged 6months-5years with moderate-to-severe atopic dermatitis
Paller, Amy S.
Cork, Michael J.
Wollenberg, Andreas
Siegfried, Elaine C.
Gonzalez, Mercedes E.
Lockshin, Benjamin
Khokhar, Faisal A.
Chen, Zhen
Gonzalez, Tayler
Simcox, Elizabeth
Prescilla, Randy
[J]. BRITISH JOURNAL OF DERMATOLOGY, 2023, 188
[49] Long Term Hematologic Laboratory Safety of Dupilumab in Patients Aged 6 Months to 5 Years With Moderate-to-Severe Atopic Dermatitis
Siegfried, Elaine
Cork, Michael J.
Lockshin, Benjamin
Boguniewicz, Mark
Uppal, Sumeet
Vass, Maria
Khokhar, Faisal A.
Bansal, Ashish
Sierka, Debra
Cyr, Sonya
[J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB62 - AB62
[50] 411 Long term laboratory safety of dupilumab in patients aged 6 months to 5 years with moderate-to-severe atopic dermatitis
Siegfried, Elaine
Cork, Michael J.
Lockshin, Benjamin
Boguniewicz, Mark
Uppal, Sumeet
Khokhar, Faisal A.
Bansal, Ashish
Sierka, Debra
Cyr, Sonya
[J]. BRITISH JOURNAL OF DERMATOLOGY, 2023, 188

← 1 2 3 4 5 →